Current status and trends of antimicrobial resistance among clinical isolates in China: a retrospective study of CHINET from 2018 to 2022Weiwei Yang, Wen’en Liu, Demei Zhu et al.|One Health Advances|2023Cited by 114
Results from the China Antimicrobial Surveillance Network (CHINET) in 2017 of the <i>In Vitro</i> Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Clinical Isolates of <i>Enterobacteriaceae</i> and <i>Pseudomonas aeruginosa</i>Dandan Yin, Fupin Hu, Shi Wu et al.|Antimicrobial Agents and Chemotherapy|2019Cited by 104
A multicenter investigation of 2,773 cases of bloodstream infections based on China antimicrobial surveillance network (CHINET)Fupin Hu, Yingyuan Zhang, Lili Yuan et al.|Frontiers in Cellular and Infection Microbiology|2022Cited by 48